Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Merseburg

4 clinical trials in Merseburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Merseburg at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Merseburg

Open in trial search
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Levetiracetam
  • Sponsor:Universitaet Leipzig
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:AIO-Studien gGmbH

Ischaemic stroke

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lt3001
  • Sponsor:Lumosa Therapeutics Co. Ltd.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxycarbamide
  • Sponsor:Novartis Pharma GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Merseburg

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on advanced colorectal cancer treatment, combining conventional chemotherapy with novel therapeutic approaches. The research aims to improve disease control rates and treatment outcomes for patients with metastatic conditions.

  • Metastatic Colorectal Carcinoma
  • Combination Therapy Assessment
  • Disease Control Optimization

These studies represent significant advancement in treatment options for patients with advanced stages of colorectal cancer.

02 Neurology Studies

Groundbreaking research in treating acute ischemic stroke and status epilepticus, with particular attention to elderly patients. These trials evaluate innovative drug therapies and their safety profiles in critical neurological conditions.

  • Stroke Treatment Innovation
  • Elderly Epilepsy Management
  • Emergency Neurological Care

The studies aim to enhance treatment protocols for time-sensitive neurological emergencies.

03 Hematology Research

Advanced studies in polycythemia vera treatment resistance, utilizing artificial intelligence to predict treatment outcomes. This research implements machine learning to optimize therapeutic approaches in blood disorders.

  • AI-Guided Treatment Prediction
  • Drug Resistance Analysis
  • Personalized Medicine Approaches

This innovative approach combines traditional medical research with cutting-edge technology to improve patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.